VELASOF TABLETS
Brand Name: Velasof
Composition: Sofosbuvir 400 mg & Velpatasvir 100 mg Tablets
Market Restriction: For India Only
Product Description
Medical Info
Velasof is a fixed-dose combination therapy containing 400 mg of Sofosbuvir and 100 mg of Velpatasvir. This powerful direct-acting antiviral (DAA) medication is primarily indicated for the treatment of chronic Hepatitis C virus (HCV) infection across all six major viral genotypes. Sofosbuvir acts as a nucleotide analog polymerase inhibitor, while Velpatasvir functions as an NS5A inhibitor; together, they effectively disrupt the viral replication cycle. Packaged as a 28-tablet regimen, this oral treatment offers a high cure rate with a simplified dosing schedule. It must be administered strictly under the guidance of a qualified healthcare professional.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
